Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Carrier Screening - Fragile X Syndrome (FMR1) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 3 | 1 |
|
Fragile X Syndrome, Mol. Analysis Mayo Clinic Laboratories Mayo Clinic United States | 4 | 1 |
|
Asuragen Clinical Laboratory Asuragen, Inc United States | 2 | 1 |
|
Invitae FMR1-Fragile X Syndrome and Related Disorders Repeat Expansion Test Invitae United States | 3 | 1 |
|
Invitae United States | 3 | 1 |
|
FMR1 - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Autism Spectrum Disorders (ASD) Panel PreventionGenetics, part of Exact Sciences United States | 224 | 170 |
|
Premature ovarian failure 1, 311360, X-linked; POF1 (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Premature ovarian failure 1, 311360, X-linked; POF1(Repeat Analysis) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae United States | 224 | 112 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Fragile X Syndrome, Diagnostic Molecular Diagnostic Laboratory LabCorp United States | 3 | 1 |
|
X-Linked Intellectual Disability Panel PreventionGenetics, part of Exact Sciences United States | 191 | 141 |
|
FMR1 Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 3 | 1 |
|
FMR1 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 3 | 1 |
|
Baylor Genetics United States | 3 | 1 |
|
Fragile X Syndrome via the FMR1 CGG Repeat Expansion PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.